These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 57447

  • 1. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis.
    Reeve J, Hesp R, Williams D, Hulme P, Klenerman L, Zanelli JM, Darby AJ, Tregear GW, Parsons JA.
    Lancet; 1976 May 15; 1(7968):1035-8. PubMed ID: 57447
    [Abstract] [Full Text] [Related]

  • 2. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
    Slovik DM, Neer RM, Potts JT.
    J Clin Invest; 1981 Nov 15; 68(5):1261-71. PubMed ID: 7298851
    [Abstract] [Full Text] [Related]

  • 3. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
    Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT.
    Br Med J; 1980 Jun 07; 280(6228):1340-4. PubMed ID: 6992932
    [Abstract] [Full Text] [Related]

  • 4. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.
    Goldsmith RS, Jowsey J, Dubé WJ, Riggs BL, Arnaud CD, Kelly PJ.
    J Clin Endocrinol Metab; 1976 Sep 07; 43(3):523-32. PubMed ID: 956340
    [Abstract] [Full Text] [Related]

  • 5. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM.
    J Clin Invest; 1993 Mar 07; 91(3):1138-48. PubMed ID: 8450043
    [Abstract] [Full Text] [Related]

  • 6. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetić K, Müller R, Bilezikian J, Lindsay R.
    J Bone Miner Res; 2001 Oct 07; 16(10):1846-53. PubMed ID: 11585349
    [Abstract] [Full Text] [Related]

  • 7. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis.
    Riggs BL, Jowsey J, Goldsmith RS, Kelly PJ, Hoffman DL, Arnaud CD.
    J Clin Invest; 1972 Jul 07; 51(7):1659-63. PubMed ID: 4338118
    [Abstract] [Full Text] [Related]

  • 8. Harnessing the parathyroids to create stronger bones.
    Silver J, Bushinsky D.
    Curr Opin Nephrol Hypertens; 2004 Jul 07; 13(4):471-6. PubMed ID: 15199299
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb 07; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 12. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis.
    Plotkin H, Gundberg C, Mitnick M, Stewart AF.
    J Clin Endocrinol Metab; 1998 Aug 07; 83(8):2786-91. PubMed ID: 9709948
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The physiology of the circadian rhythm of parathyroid hormone and its potential as a treatment for osteoporosis.
    Fraser WD, Ahmad AM, Vora JP.
    Curr Opin Nephrol Hypertens; 2004 Jul 07; 13(4):437-44. PubMed ID: 15199294
    [Abstract] [Full Text] [Related]

  • 15. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May 07; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
    Slovik DM, Rosenthal DI, Doppelt SH, Potts JT, Daly MA, Campbell JA, Neer RM.
    J Bone Miner Res; 1986 Aug 07; 1(4):377-81. PubMed ID: 3503551
    [Abstract] [Full Text] [Related]

  • 18. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
    Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP.
    J Clin Endocrinol Metab; 2000 Sep 07; 85(9):3069-76. PubMed ID: 10999788
    [Abstract] [Full Text] [Related]

  • 19. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
    Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ, PaTH Study Investigators.
    N Engl J Med; 2003 Sep 25; 349(13):1207-15. PubMed ID: 14500804
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S, Gol M, Cimrin D, Irmak E.
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov 01; 123(1):67-71. PubMed ID: 16051419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.